CHF - MSB's Dark Horse with Multi-billion dollar potential, page-327

" oh now there's Covid let's try that!"

Pinning that on Mesoblast is pure BS.

Of course Mesoblast could have said no, go away we are not interested in participating, because it cannot possibly work or it would be a waste of resources or non share holders will get upset etc. The National Institutes of Health clearly decided it was worth doing or they would not have picked up the tab for time and resources, while Mesoblast (we) picked up the tab for the cells and the supply chain.

Who ran the trials, who did the urgent paperwork for the preliminary study, who was the responsible party, who funded the trial, who supplied the cells for testing at no charge to NHLBI to do the work.

Was SI fully informed on the progress of the preliminary study, that would be - not always.

The first press release by the Mount Sinai Health System
https://www.mountsinai.org/about/newsroom/2020/mount-sinai-leading-the-way-in-innovative-stem-cell-therapy-for-covid19-patients-pr

Key details on various parties to the P3 Trial.
https://clinicaltrials.gov/ct2/show/NCT04371393?term=mesoblast&cond=ARDS&draw=2&rank=2


Dinner calls